Human Reproduction Update, Vol.9, No.2 pp.185-192, 2003
© European Society of Human Reproduction and Embryology 2003; all rights reserved
Results of conservative management of epithelial malignant and borderline ovarian tumours
1 Department of Gynecologic Surgery, Institut Gustave-Roussy, Villejuif, France 2 Department of Gynecology, Institut Gustave-Roussy, Villejuif, France 3 Department of Pathology, Institut Gustave-Roussy, Villejuif, France
To whom correspondence should be addressed at: Philippe Morice, Service de Chirurgie Gynécologique, Institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif Cedex, France. e-mail: morice{at}igr.fr
Abstract
Conservative management of at least part of both the ovary and uterus can be proposed in patients with borderline ovarian tumour, in order to preserve fertility potential. This conservative management could be carried out even in patients with borderline ovarian tumour associated with non-invasive peritoneal implants (if complete resection of peritoneal disease has been performed). When facing persistent infertility after this conservative surgery, ovarian induction or an in-vitro procedure could be proposed in patients with an early-stage disease, though the number of attempts must be limited. Removal of the preserved ovary after completion of pregnancy(ies) is unnecessary if patients agree to careful follow-up. In patients with epithelial ovarian cancer, conservative management could safely be performed in young patients who wish to preserve fertility function and who fulfil the following criteria: unilateral tumour (stage IA), grade 1 (and 2?), adequate staging surgery and careful follow-up. Removal of the preserved ovary should be carried out after completion of pregnancy(ies) in order to reduce the risk of ovarian tumour recurrence.
Key words: borderline tumour / conservative surgery / infertility treatment / ovarian cancer / pregnancy
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Palomba, E. Zupi, T. Russo, A. Falbo, S. Del Negro, F. Manguso, D. Marconi, A. Tolino, and F. Zullo Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study Hum. Reprod., February 1, 2007; 22(2): 578 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Basille, F. Olivennes, J. Le Calvez, N. Beron-Gaillard, G. Meduri, C. Lhomme, P. Duvillard, J. Benard, and P. Morice Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours Hum. Reprod., December 1, 2006; 21(12): 3241 - 3245. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Poncelet, R. Fauvet, J. Boccara, and E. Darai Recurrence After Cystectomy for Borderline Ovarian Tumors: Results of a French Multicenter Study Ann. Surg. Oncol., April 1, 2006; 13(4): 565 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Morice, E. Leblanc, A. Rey, M. Baron, D. Querleu, J. Blanchot, P. Duvillard, C. Lhomme, D. Castaigne, J. M. Classe, et al. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Societe Francaise d'Oncologie Gynecologique) Hum. Reprod., May 1, 2005; 20(5): 1379 - 1385. [Abstract] [Full Text] [PDF] |
||||

